Skip to main content

Table 1 Characteristics of the patients with IBD

From: Clinical significance of soluble immunoglobulins A and G and their coated bacteria in feces of patients with inflammatory bowel disease

  HC CD UC
Number of patients 41 178 75
Age (years) 33.6 ± 10.3 33.7 ± 12.2 41.2 ± 14.9
Gender
 Male 18 115 43
 Female 23 63 32
Active/remission   80/98 54/21
Disease duration (months)   35.3 ± 16.3 34.4 ± 18.1
Current therapy
 5-Aminosalicylates   63 49
 Salazosulfapyridine   1 3
 Azathioprine   47 6
 Glucocorticoids   18 20
 Methotrexate   6 4
 Biologics   63 2
 Nutritional therapy   45 6
Age (CD)a
 A1   14  
 A2   122  
 A3   42  
Disease location (CD)a
 L1   57  
 L2   49  
 L3   72  
Disease behavior (CD)a
 B1   99  
 B2   65  
 B3   14  
 P   33  
Disease phenotype (UC)a
 E1    16
 E2    23
 E3    34
  1. aAccording to the Montreal classification system